About Us

MISSION
VISION

Our mission is to reduce the impact of vector-borne diseases and contribute to their eventual elimination by improving the product development landscape for vector control tools, supporting enhanced evaluation processes, facilitating sustained quality of vector control products and improving their judicious and safe use with a focus on shortening time to market.

Our vision is a development environment for vector control products conducive to dialogue, innovation and investment and which efficiently delivers a steady stream of new, quality tools to those who need them most, and safeguards their continued effectiveness.

Children outside their house during IRS campaign, Ethiopia, Brant Stewart, RTI, PMI, 2014

Rationale

Approximately 80% of the global population is at risk from vector-borne disease leading to over 700,000 deaths annually, predominantly in sub-Saharan Africa. Vector borne diseases, such as malaria, dengue, yellow fever and Zika and chikungunya pose a huge threat to the world, affecting not only health outcomes, but also serve to slow economic growth and…

READ MORE
Net Distribution In Mwanza, Tanzania, Riccardo Gangale/VectorWorks, Courtesy of Photoshare, 2016

Approach

I2I’s work focuses on four overarching objectives:

  • Innovation: Creating a more conducive environment for innovation and product development;
  • Efficiency: Improving evaluation pathways to allow streamlined data generation to accelerate registration and uptake of new tools;
  • Quality: Developing rigorous quality assurance systems to ensure the lasting impact of new products;
  • Dialogue: Improving dissemination and understanding of WHO pre-qualification processes with vector control stakeholders;

I2i convenes vector control stakeholders such as global and country policy makers, product developers, donors, regulators, academia and programme implementers to streamline the evaluation and registration of new vector control tools.

IRS spray operator with family during IRS campaign, Rwanda, Brant Stewart, RTI, PMI, 2014

Areas of Involvement

Ifakara Health InstituteTanzania

National Institute of Medical ResearchTanzania

PAMVERC-KCMUCo Test FacilityTanzania

CREC, CotonouBenin

Institut de Recherche en Sciences de la Santé (IRSS)Burkina Faso

Centre Suisse de Recherches ScientifquesCôte D'Ivoire

Institut Pierre Richet (IPR)Côte D'Ivoire

Centro de Investigations de Plagas e Insecticides (CIPEIN)Argentina

Fundação Oswaldo Cruz (FIOCRUZ)Brazil

University of ColombiaColombia

Collaborative Unit for Entomological BioassaysMexico

National Institute of Malaria ResearchIndia

Vector Control Research CentreIndia

National Institute for Communicable Disease Control and PreventionChina

Institute for Medical ResearchMalaysia

Vector Control Research UnitMalaysia

A To Z Textile Mills LtdTanzania

BASFGermany

BayerGermany

Bill & Melinda Gates FoundationUSA

ClariantSwitzerland

ClarkeUSA

Disease Control Technologies (DCT)USA

HD Sudson SprayersUSA

In2Care BVNetherlands

MainpolGermany

Mitsui ChemicalsJapan

Moon NettingDenmark

Real ReliefDenmark

SC Johnson (SCJ)USA

Sumitomo ChemicalJapan

SyngentaSwitzerland

VestergaardSwitzerland

Yorkool Private LtdChina

African Leaders Malaria Alliance (ALMA)Tanzania

African UnionEthiopia

Comite Inter-Etats des Pesticides de l'Afrique CentraleCameroon

Roll Back Malaria Partnership (RBM)Switzerland

World Health Organization (WHO)Switzerland

The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)Switzerland

President's Malaria Initiative (PMI)USA

UnicefDenmark

UnitaidSwitzerland

USAIDUSA

IVCCUK

GLP Testing Sites
Industry
International Organisations
Procurers and Funders

Leadership Team

Angus Spiers

Director
[email protected]

Angus leads the strategic agenda of i2i and manages the relationships with all major stakeholders. His role is focussed on finding stakeholder consensus on shared challenges and catalysing solutions to these. Prior to this role, he was Senior Malaria Advisor at the President’s Malaria Initiative. He formerly served as UNICEF’s Regional Malaria Advisor in Angola, as PSI’s Deputy Director of Malaria and Child Survival, and as a Senior Technical Advisor at USAID/PMI. Angus holds a PhD from the Liverpool School of Tropical Medicine.

Alison Reynolds

Technical Programme Manager
[email protected]

Alison oversees the programme and financial management of i2i activities and facilitates communications and collaboration across in-country partners, regulators, field implementers, malaria control programmes and other stakeholders. She also has particular involvement in coordinating the activities of the GLP and Country Registration workstreams and disseminating outputs. Alison has over 15 years’ experience in project management in academic and operational research including positions with the Malaria in Pregnancy Consortium at LSTM and the Malaria Modelling Research Group at Imperial College London. More recently Alison has managed projects in the LSTM Vector Biology Department focusing on the implementation of digital tools to facilitate better data driven decision making and capacity strengthening for vector borne-disease control programmes.

Angus Spiers Director

[email protected]

Angus leads the strategic agenda of i2i and manages the relationships with all major stakeholders. His role is focussed on finding stakeholder consensus on shared challenges and catalysing solutions to these. Prior to this role, he was Senior Malaria Advisor at the President’s Malaria Initiative. He formerly served as UNICEF’s Regional Malaria Advisor in Angola, as PSI’s Deputy Director of Malaria and Child Survival, and as a Senior Technical Advisor at USAID/PMI. Angus holds a PhD from the Liverpool School of Tropical Medicine.

Alison Reynolds Technical Programme Manager

[email protected]

Alison oversees the programme and financial management of i2i activities and facilitates communications and collaboration across in-country partners, regulators, field implementers, malaria control programmes and other stakeholders. She also has particular involvement in coordinating the activities of the GLP and Country Registration workstreams and disseminating outputs. Alison has over 15 years’ experience in project management in academic and operational research including positions with the Malaria in Pregnancy Consortium at LSTM and the Malaria Modelling Research Group at Imperial College London. More recently Alison has managed projects in the LSTM Vector Biology Department focusing on the implementation of digital tools to facilitate better data driven decision making and capacity strengthening for vector borne-disease control programmes.

Steering Committee

The role of the Steering Committee members is to:

  • Provide independent expertise and actionable guidance to support strategic direction of I2I programme;
  • Agree objectives and workplans with I2I Leadership Team;
  • Promote accountability of the I2I Leadership Team in attaining programme objectives;
  • Work to actively support I2I to achieve its aims and objectives;
  • Monitor progress and performance of the I2I programme;

Mark Hoppe

IRAC and Methods Representative

Syngenta

Senior Team Leader, Public Health

Mark Hoppé is a Public Health entomologist with 30 years’ experience of research, development and advocacy in agricultural and public health insect control. He is currently involved in the development of novel solutions for the control of insects of public health importance, working for Syngenta in Switzerland. Mark studied Crop Protection at Bath University, and holds an MBA in technology management. He is also the chair of the Insecticide Resistance Action Committee’s (IRAC) Public Health team, co-chairs the Roll Back Malaria VCWG’s Integrated Vector Management (IVM) and Insecticide Resistance Management (IRM) workstream, and is a Fellow of the Royal Entomological Society.

Chris Kanema

Regulatory Representative

Zambia Environmental Management Agency

Principal Investigator & Head Pesticides & Toxic Substances

Christopher Kanema works for the Zambia Environmental Management Agency (ZEMA) as Principal Inspector and Heads the Unit responsible for sound management of Pesticides and Toxic Substances in Zambia. He has coordinated several projects in Zambia on sound management of chemicals in general and pesticides in particular. He is currently the focal point for the Rotterdam Convention on Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade as well as the focal point of the Minamata Convention on Mercury. In his capacity as a focal point, he has represented Zambia in the Conference of the Parties meetings. He is a member of several Technical Committees including the Southern African Pesticides Regulators Forum (SAPReF) and I2I.

Corine Karema

Africa Policy Representative

African Leaders Malaria Alliance

Malaria Senior Programme Officer

Corine Karema is the former Director of the Rwanda National Malaria Control Program (NMCP), where she served in this role for ten years (2006 – 2016). Also, from 2011 to May 2016, she was the head of Malaria & Other Parasitic Diseases (Neglected tropical diseases) Division – Rwanda. During her time at the NMCP, she led the development of malaria control strategies, policies, and research, which has guided the implementation of evidence-based malaria control interventions resulting in increased coverage of critical malaria control interventions with important reductions in malaria morbidity and mortality in Rwanda. Her research has mainly focused on malaria, NTDs, Maternal and child health, as well as epidemiological and public health research. Corine was also the Co-chair of the East African Roll Back Malaria (RBM) Network Coordination committee and member of the diverse WHO scientific and advisory committees including the Global Malaria Control and Elimination technical working group; WHO Steering committee of the Global Technical Strategy for Malaria control and elimination 2016-2030 and RBM GMAP II Task Force.

Marion Law

Regulatory Representative

WHO PQ

Group Lead, WHO Pre-Qualification

Marion Law, the Team Lead of the Vector Control Products Team, is a microbiologist with research experience in the area of antibiotic and microbial resistance. Before joining WHO three years ago, she held a number of senior executive positions in Health Canada which included, leading health product evaluation, science policy development and regulatory science operations in the areas of pharmaceuticals, medical devices, control drugs and substances, blood products, and biotechnology drugs as well as pesticides and pest control products. As a previous Chief Registrar of the Pest Management Regulatory Agency of Health Canada, and more recently the Director General of the Therapeutic Products Directorate, Health Canada she has extensive international experience including as head of the Canadian delegation to NAFTA and also to the OECD where she was the Chair of the OECD Working Group on Pesticides.

Dave Malone

Product Development and GLP Representative

Bill & Melinda Gates Foundation

Senior Programme Officer, Vector Control, Malaria

David Malone, Senior Programme Officer for Vector Control at the BMGF, is an entomologist, with research experience in the area of insecticide resistance and vector biology. Before joining BMGF, David held a role as Senior Business Development Manager for Sumitomo Chemical and prior to this was Technical Manager at the Innovative Vector Control Consortium (IVCC) in Liverpool. Previously he worked as a civilian medical entomologist for the British Military, at the Cayman Islands Mosquito Research and Control Unit and as Director of Research and Technical Services for the Florida based company Adapco.

Corine Ngufor

GLP and Testing Representative

CREC

Assistant Professor, Medical Entomology

Dr Corine Ngufor is Assistant Professor of medical entomology at the London School of Hygiene & Tropical Medicine and lead scientist at the CREC/PAMVERC Research unit in Benin. Her research focuses on the identification of new vector control tools for improved control of pyrethroid-resistant malaria vectors. Corine has several years of experience in the evaluation of vector control products. She has led several IVCC, Industry and WHO-funded research projects contributing to the development of novel LLIN and IRS products and is currently one of the lead investigators of a large-scale UNITAID/Global Fund/IVCC-funded community trial investigating the efficacy of two next-generation LLINs in Benin. As Manager of the CREC/PAMVERC unit, Corine led the Facility to Good Laboratory Practice (GLP) certification becoming the first in West Africa to achieve this status for vector control product evaluation. She has also contributed to the development of high level standard operating procedures and WHO guidelines for evaluating new vector control tools.

Hilary Ranson

Methods Representative

Liverpool School of Tropical Medicine

Professor, Medical Entomology

Professor Hilary Ranson is a vector biologist whose research focuses on the control of mosquito borne disease, particularly on the use of insecticides in public health. She has led several international consortia to develop and evaluate new approaches for malaria control and currently leads a major interdisciplinary programme to increase the impact of vector control in sub Saharan Africa by filling capacity gaps, strengthening linkages between research and policy, and integrating approaches to target multiple vector borne diseases. Professor Ranson is a member of the Vector Control Advisory Group and provides additional ad hoc technical support to WHO. She works closely with industry partners and has established a testing service at LSTM to evaluate potential new vector control tools against a range of characterized mosquito populations from the field.

Graham Small

Product Development, GLP and Methods Representative

IVCC

Trials Quality and Project Support Manager

Graham has more than 30 years' experience in entomological research including laboratory and field studies on mosquito vectors of disease. He has expertise in pesticide resistance research, pest control product efficacy testing, and the development and implementation of quality management systems compliant with the OECD principles of Good Laboratory Practice. Following his PhD at the London School of Hygiene & Tropical Medicine (supervised by Professor Janet Hemingway) and postdoctoral research at Cardiff University, Graham took the sideways step into industry becoming Technical Director at a CRO conducting product testing for the pest control industry. He then established his own successful consultancy before joining IVCC in 2016. At IVCC, Graham is responsible for supporting the GLP certification of collaborating African trials facilities, trials capacity resource planning, quality management and facility relationship management. He is also technical lead and support on new and repurposed active ingredient projects, insecticide analysis, formulation and biochemistry projects. Graham is a Member of the UK Research Quality Association and Fellow of the Royal Entomological Society. He was previously a consultant to WHO on GLP certification and was for 10 years a member of IVCC’s External Scientific Advisory Committee (ESAC).

Sheila Tamara Shawa-Musonda

Africa Policy Representative

African Union

Senior Programme Officer

Sheila Tamara Shawa (Ph.D.) is a Senior Program Officer at the Africa Union Commission in the department of Social Affairs under the AIDS, TB, Malaria and Other infectious diseases (ATM & OIDs) division. She is the focal person for TB, NTDs and the CHWs workers initiative. Dr Shawa possesses expertise in diseases control programs with over 10 years extensive experience in public health, policy formulation & advocacy, and preparedness to epidemics. Dr Shawa was instrumental in the establishment of the Africa CDC as senior project officer where she was responsible for coordinating activities in the regional collaborating centres including in Central, Eastern and Southern Africa and technical activities at HQ. Dr Shawa coordinated the development of 5 year Strategic Plan of the Africa CDC.

Mark Hoppe IRAC and Methods Representative

Chris Kanema Regulatory Representative

Corine Karema Africa Policy Representative

Marion Law Regulatory Representative

Dave Malone Product Development and GLP Representative

Corine Ngufor GLP and Testing Representative

Hilary Ranson Methods Representative

Graham Small Product Development, GLP and Methods Representative

Sheila Tamara Shawa-Musonda Africa Policy Representative